Exploring the Potential of CSTF1 as a Prognostic Biomarker in Hepatocellular Carcinoma and Its Correlation with Immune Infiltration
These findings suggest that CSTF1 can serve as a novel prognostic biomarker for HCC. Evidence from immunohistochemistry and bioinformatics analyses supports CSTF1 as a prognostic indicator and a potential therapeutic target. This discovery could enhance diagnostic precision and improve survival outcomes for patients with HCC.
Authors
- Maimaitiming Aimaiti
- Zhiqiang Jia (ORCID: https://orcid.org/0000-0003-1524-668X)
- Ainiwaerjiang Abudourousuli
- Junling Zhu (ORCID: https://orcid.org/0009-0002-3915-1220)
- Mieradilijiang Ainiwaer
- Dilimulati Maimaitituxun
- Xiaokaiti Yilihaer
- Talifujiang Kuerban
Institutions
- Xinjiang Medical University (CN)
- People's Hospital of Kaizhou District (CN)
- The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture (CN)
- People's Hospital of Xinjiang Uygur Autonomous Region (CN)
Publication Details
- Journal
- Journal of Hepatocellular Carcinoma
- Published
- 2025-12-01
- DOI
- https://doi.org/10.2147/jhc.s552710
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00